Cargando…
Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice
INTRODUCTION: In this prospective, multicenter, observational cohort study, the effectiveness and tolerability of the first fixed-dose combination (FDC) formulation of the selective heart rate reducing agent ivabradine and the beta-blocker metoprolol was evaluated in stable angina pectoris (AP) pati...
Autores principales: | Divchev, Dimitar, Stöckl, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688976/ https://www.ncbi.nlm.nih.gov/pubmed/29116618 http://dx.doi.org/10.1007/s40119-017-0099-1 |
Ejemplares similares
-
Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice
por: Divchev, Dimitar, et al.
Publicado: (2019) -
Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice
por: Perings, Stefan, et al.
Publicado: (2016) -
Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention
por: Werdan, Karl, et al.
Publicado: (2015) -
Effectiveness of Ivabradine in Treating Stable Angina Pectoris
por: Ye, Liwen, et al.
Publicado: (2016) -
Ivabradine for the Therapy of Chronic Stable Angina Pectoris
por: Kim, Soo-Joong
Publicado: (2020)